NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01804790,Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer,https://clinicaltrials.gov/study/NCT01804790,Néofirinox,ACTIVE_NOT_RECRUITING,"National, multi-center, open-label,randomized, 2-arm phase III superiority trial, comparing neoadjuvant chemotherapy (CT) with mFolfirinox followed by preoperative chemoradiotherapy (CRT), versus preoperative CRT in patients with locally advanced rectal cancer.",NO,Cancer of the Rectum,DRUG: mFolfirinox|RADIATION: Radiotherapy 50 Gy|DRUG: Capecitabine|PROCEDURE: TME surgery|DRUG: mFolfox6 or capecitabine,"disease-free survival, To compare the 3-year disease-free survival between the investigational arm and the control arm., 3 years","Overall survival, Overall survival will be defined as the time from randomisation to the time of occurrence of the first death regardless to its cause. Patients alive at the time of analysis will be censored at the date of the last follow up., 7 years",,UNICANCER,,ALL,"ADULT, OLDER_ADULT",PHASE3,461,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,PRODIGE 23 - UCGI 23|2011-004406-25,2012-01,2019-09,2025-05,2013-03-05,,2024-10-01,"Centre hospitalier Universitaire d'Amiens, Amiens, France|ICO - Site Paul Papin, Angers, France|Centre hospitalier d'Auxerre, Auxerre, France|Centre Hospitalier de Beauvais, Beauvais, France|Institut de Cancérologie de Franche Comté, Besancon, France|Centre Hospitalier de Blois, Blois, France|Hopital Avicenne, Bobigny, France|Clinique Tivoli, Bordeaux, France|Hopital Saint Andre, Bordeaux, France|Institut Bergonie, Bordeaux, France|Centre Francois Baclesse, Caen, France|Chd de La Roche Sur Yon - Les Oudairies, La Roche-sur-yon, France|Centre Bourgogne, Lille, France|Centre Oscar Lambret, Lille, France|Centre Léon Bérard, Lyon, France|Hopital Prive Jean Mermoz, Lyon, France|Ap Hm - Hopital de La Timone - Adultes, Marseille, France|Institut de Cancérologie de Franche Comté, Montbeliard, France|Centre Azuréen de cancérologie, Mougins, France|Hopital Emile Muller, Mulhouse, France|centre Alexis Vautrin, Nancy, France|Polyclinique de Gentilly, Nancy, France|Centre Antoine Lacassagne, Nice, France|Groupe Hospitalier La Pitie-Salpetriere, Paris, France|Institut Mutualiste Montsouris, Paris, France|Hopital Haut Leveque, Pessac, France|Centre Hospitalier Regional D'Annecy, Pringy, France|Hopital Robert Debre, Reims, France|Institut Jean Godinot, Reims, France|Clinique Armoricaine de Radiologie, Saint-brieuc, France|Hopital Saint Gregoire, Saint-gregoire, France|Clinique Mutualiste de L'Estuaire, Saint-nazaire, France|Centre Hospitalier de la Réunion - Site du GHSR, Saint-pierre, France|ICO - Site René Gauducheau, St Herblain, France|Centre Paul Strauss, Strasbourg, France|Gustave Roussy, Villejuif, France",
